Related Experiment Videos
Can CSF predict the course of optic neuritis?
1Department of Neurology, Glostrup Hospital, University of Copenhagen, Denmark.
Summary
Cerebrospinal fluid (CSF) abnormalities, including oligoclonal IgG bands and virus-specific antibodies, may indicate a higher risk of developing multiple sclerosis (MS) after acute monosymptomatic optic neuritis (AMON). Further research is needed to confirm prognostic value.
Area of Science:
- Neurology
- Immunology
- Neuroimmunology
Background:
- Acute monosymptomatic optic neuritis (AMON) is an inflammatory demyelinating event of the optic nerve.
- Understanding cerebrospinal fluid (CSF) abnormalities can offer insights into the disease course and prognosis of AMON.
- Previous studies on CSF markers in AMON have yielded conflicting results regarding their predictive value for multiple sclerosis (MS) development.
Purpose of the Study:
- To investigate the implications of various CSF abnormalities for the clinical course of AMON.
- To assess the prognostic value of CSF markers for the development of clinically definite multiple sclerosis (CDMS) in AMON patients.
Main Methods:
- A population-based cohort of AMON patients was randomly selected for analysis.
- Paired serum and CSF samples were collected within weeks of AMON onset.
- CSF analysis included oligoclonal IgG bands, free light chains, virus-specific antibodies, and Myelin Basic Protein (MBP)-like material.
Main Results:
- CSF-restricted oligoclonal IgG bands were found in 17/27 patients, free kappa and lambda chain bands in 15/27 and 9/27, respectively.
- Intrathecal synthesis of virus-specific oligoclonal IgG antibodies was detected in 16/27 patients.
- Five patients developed CDMS within 1 year; all exhibited CSF oligoclonal IgG bands and virus-specific antibodies at onset.
- Elevated CSF MBP-like material was infrequent (2/29) but potentially correlated with disease activity and visual impairment severity.
Conclusions:
- The presence of CSF oligoclonal IgG bands and virus-specific antibodies at AMON onset may be associated with a higher risk of progressing to CDMS.
- Short-term follow-up and small sample size limit definitive conclusions on the prognostic value of these CSF markers.
- CSF MBP-like material warrants further investigation for its potential role in reflecting AMON disease activity and severity.